Pipeline Setbacks for Big Pharma: AZ, Sanofi, Novartis, GSK Take Hits

Big Pharma saw several pipeline setbacks in December, with AstraZeneca, Sanofi, Novartis and GlaxoSmithKline (GSK) announcing trial failures, a study termination and the end of a drug development program.
Clinical Trials Advisor